(Q28265319)

27 March 2017

0 references

Ashley I Bush

4

0 references

Michael Berk

object named as

Michael Berk

2

0 references

Olivia M. Dean

3

object named as

Olivia Dean

1 reference

27 March 2017

author name string

Felicity Ng

1

1 reference

27 March 2017

Ashley I. Bush

4

1 reference

27 March 2017

language of work or name

English

0 references

publication date

September 2008

0 references

21 January 2008

1 reference

The International Journal of Neuropsychopharmacology

27 March 2017

published in

1 reference

27 March 2017

volume

11

1 reference

27 March 2017

issue

6

0 references

06

1 reference

Fine mapping of a susceptibility locus for bipolar and genetically related unipolar affective disorders, to a region containing the C21ORF29 and TRPM2 genes on chromosome 21q22.3.

27 March 2017

page(s)

851-76

0 references

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Elevated plasma lipid peroxides at the onset of nonaffective psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Lower serum vitamin E concentrations in major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: A possible role for lithium antioxidant effects

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

THE LACTIC ACID AND GLUTATHIONE CONTENT OF THE BLOOD OF SCHIZOPHRENIC PATIENTS.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Antioxidant effect of phenelzine on MPP+-induced cell viability loss in differentiated PC12 cells

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Increased oxidative stress and DNA damage in bipolar disorder: A twin-case report

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidants, oxidative stress and the biology of ageing

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Redox control of apoptosis: an update

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative stress responses in older men during endurance training and detraining

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Magnetic resonance imaging of the thalamus and adhesio interthalamica in twins with schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The effect of polyphenolic extract from pine bark, Pycnogenol on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD)

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Effect of the extract of Ginkgo biloba (EGb 761) on the circulating and cellular profiles of polyunsaturated fatty acids: correlation with the anti-oxidant properties of the extract

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative stress in blood platelets from schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Chronic lithium treatment has antioxidant properties but does not prevent oxidative damage induced by chronic variate stress.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative stress in the hippocampus, anxiety-like behavior and decreased locomotory and exploratory activity of adult rats: effects of sub acute vitamin A supplementation at therapeutic doses.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative stress: the paradox of aerobic life

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Chronic Stimulation of D1 Dopamine Receptors in Human SK-N-MC Neuroblastoma Cells Induces Nitric-oxide Synthase Activation and Cytotoxicity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Dopaminergic and adrenergic toxicities on SK-N-MC human neuroblastoma cells are mediated through G protein signaling and oxidative stress

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Glutathione peroxidase and CT scan abnormalities in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Positive correlation between peripheral blood granulocyte oxidative status and level of anxiety in mice.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Non-antioxidant activities of vitamin E.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Vitamin C and Vitamin E for Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Lithium blocks 45Ca2+ uptake into platelets in bipolar affective disorder and controls

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The platelet intracellular calcium response to serotonin is augmented in bipolar manic and depressed patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The effect of extract of ginkgo biloba added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The effect of risperidone treatment on superoxide dismutase in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Neurodegenerative diseases and oxidative stress

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

N-acetyl cysteine-induced blockade of cocaine-induced reinstatement

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Biomarkers of oxidative stress in schizophrenic and control subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Investigation of antioxidant enzymes in children with autistic disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Molecular mechanism of alpha-tocopherol action

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Altered vascular phenotype in autism: correlation with oxidative stress.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Reduced level of plasma antioxidant uric acid in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Reduced status of plasma total antioxidant capacity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Increased nitric oxide radicals in postmortem brain from patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Altered glutathione redox state in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Impairment of several immune functions in anxious women

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Is the Arginine-Nitric Oxide Pathway Involved in the Pathogenesis of Schizophrenia?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Serum S100B and antioxidant enzymes in bipolar patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The relationship between potency of oxidative stress and severity of depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Does ascorbate/L-Cys/L-Met mixture protect different parts of the rat brain against chronic alcohol toxicity?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Olanzapine and quetiapine protect PC12 cells from beta-amyloid peptide(25-35)-induced oxidative stress and the ensuing apoptosis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG).

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Moclobemide attenuates anoxia and glutamate-induced neuronal damage in vitro independently of interaction with glutamate receptor subtypes.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Long-term treatment effects of vitamin E for tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Hippocampal volumes in schizophrenic twins

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Free radicals and antioxidants in normal physiological functions and human disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Biomarkers for oxidative stress: clinical application in pediatric medicine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Treatment of ADHD with French maritime pine bark extract, Pycnogenol.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Vitamin E, antioxidant and nothing more

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Free radicals in patients with post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

An experimental comparison of Pycnogenol and methylphenidate in adults with Attention-Deficit/Hyperactivity Disorder (ADHD).

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Haloperidol and reduced haloperidol concentrations and psychiatric ratings in schizophrenic patients treated with ascorbic acid

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

A study on nitric oxide, beta-adrenergic receptors and antioxidant status in the polymorphonuclear leukocytes from the patients of depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Thiobarbituric acid reactive substances in the cerebrospinal fluid in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative stress: oxidants and antioxidants

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Untreated Depression and Hippocampal Volume Loss

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Genetic polymorphism of glutathione S-transferase T1: a candidate genetic modifier of individual susceptibility to schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Clinical pharmacology and therapeutic use of antioxidant vitamins

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Reduced plasma antioxidants in first-episode patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vasopressin and glyoxalase-I.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Cytoprotection by lithium and valproate varies between cell types and cellular stresses

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Antioxidant enzyme and malondialdehyde levels in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative Stress During Treatment With First- and Second-Generation Antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Unifying mechanism for toxicity and addiction by abused drugs: electron transfer and reactive oxygen species

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Unifying mechanism for addiction and toxicity of abused drugs with application to dopamine and glutamate mediators: electron transfer and reactive oxygen species

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

DNA damage and repair efficiency in lymphocytes from schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Effects of nicotine replacement therapy on markers of oxidative stress in cigarette smokers enrolled in a smoking cessation program

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Effects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative status in patients with alcohol dependence: a clinical study in Taiwan

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative stress in heroin administered mice and natural antioxidants protection.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Opposite effects of antioxidants on anxiety in Wistar and OXYS rats.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Elevated nitric oxide/peroxynitrite mechanism for the common etiology of multiple chemical sensitivity, chronic fatigue syndrome, and posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The role of mitochondrial dysfunction in bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Glutathione as a cerebral substrate in depressive behavior.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Nitric oxide and peroxynitrite in health and disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Antioxidant enzyme activities and oxidative stress in affective disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Low plasma vitamin E levels in major depression: diet or disease?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

N-acetyl cysteine in the treatment of grooming disorders.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Increased excretion of a lipid peroxidation biomarker in autism.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Immediate effects of shock therapies, epinephrine and ACTH on blood glutathione level of psychotic patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

A functional glutathione S-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Oxidative stress and neurodegeneration: where are we now?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707008401

7 January 2021